PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01

Reported: February 27, 2019 Initiated: January 31, 2019 #D-0507-2019

Product Description

Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01

Reason for Recall

Failed Dissolution Specifications: Out of specification results observed for high dissolution.

Details

Units Affected
10,656 bottles
Distribution
U.S.A. Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 10,656 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification results observed for high dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 27, 2019. Severity: Moderate. Recall number: D-0507-2019.